Can a maculopapular rash occur in a patient with influenza A infection, particularly when they are receiving amoxicillin?

Can a Maculopapular Rash Occur During Influenza Type A Infection?

Yes, a maculopapular rash can occur during influenza A infection, but it is far more likely to be caused by amoxicillin administration rather than the influenza virus itself. When a patient with influenza A develops a maculopapular rash while receiving amoxicillin, the primary concern is drug-induced hypersensitivity, not a direct viral manifestation.

Understanding the Clinical Context

Amoxicillin as the Primary Culprit

• Amoxicillin causes maculopapular rashes in a significant proportion of patients, particularly when administered during viral infections. 1
• The FDA explicitly warns that amoxicillin may cause severe cutaneous adverse reactions (SCAR), including maculopapular eruptions that can progress to Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome, and acute generalized exanthematous pustulosis. 1
• The timing is critical: maculopapular rashes from amoxicillin typically appear roughly 1 week after drug initiation during upper respiratory tract infections. 2

Viral Infections Amplify Rash Risk

• Concurrent viral infections dramatically increase the likelihood of developing a maculopapular rash when taking amoxicillin. 2, 3
• In children with viral illnesses treated with amoxicillin, DRESS-like rashes with prominent midface edema and maculopapular eruptions can appear within days of drug intake, mimicking severe drug reactions. 2
• A 2025 case report demonstrated that amoxicillin-clavulanic acid induced a widespread maculopapular rash in a patient with Epstein-Barr virus infection, highlighting how viral infections predispose to aminopenicillin-associated rashes. 3

Diagnostic Algorithm

Step 1: Immediate Assessment

• Discontinue amoxicillin immediately if a maculopapular rash develops. 1
• Monitor closely for progression to severe cutaneous adverse reactions, particularly if lesions evolve beyond simple macules and papules. 1

Step 2: Differentiate Drug Reaction from Viral Exanthem

Check for eosinophilia:

• Absence of eosinophilia suggests a viral-induced rash rather than early DRESS syndrome. 2
• Presence of eosinophilia strongly indicates drug hypersensitivity and should prompt consideration of DRESS syndrome. 2

Assess timing and clinical course:

• Rashes appearing ≤15 days after amoxicillin initiation with systemic symptoms suggest early-onset DRESS. 2
• Rapid resolution within 2-5 days after drug discontinuation favors a viral etiology or benign drug reaction. 2
• Persistent or progressive rash despite drug cessation raises concern for true drug hypersensitivity. 2

Calculate RegiSCAR score:

• A low RegiSCAR score (2-3) combined with confirmed viral etiology helps rule out DRESS syndrome. 2

Step 3: Confirm Viral Etiology

• Document influenza A infection through appropriate testing (NAAT or RT-PCR preferred). 4, 5
• Consider testing for other viral pathogens (EBV, parvovirus B19) that commonly cause maculopapular rashes during antibiotic therapy. 6, 3

Critical Management Principles

Antibiotic Stewardship in Influenza

Most patients with influenza do not require antibiotics:

• Previously well adults with acute bronchitis complicating influenza, in the absence of pneumonia, do not routinely require antibiotics. 7
• The strong recommendation against antibiotics in non-severe influenza without bacterial co-infection should prevent unnecessary amoxicillin exposure and subsequent rash development. 4

When antibiotics are indicated:

• If pneumonia is confirmed or bacterial co-infection is suspected, co-amoxiclav (not plain amoxicillin) is the preferred agent because it provides necessary S. aureus coverage. 7, 8
• For patients with documented penicillin allergy, use a respiratory fluoroquinolone (levofloxacin or moxifloxacin) or a macrolide plus appropriate coverage. 7, 9

Avoiding Diagnostic Pitfalls

Common mistake: Attributing the rash to influenza rather than amoxicillin

• Influenza A itself rarely causes maculopapular rashes; the virus typically presents with respiratory symptoms, fever, and myalgias without cutaneous manifestations. 6
• When a rash appears during influenza treatment with amoxicillin, the drug is the most likely cause. 2, 3

Common mistake: Permanent "amoxicillin allergy" labeling

• Many viral-induced rashes during amoxicillin therapy are not true drug allergies. 2
• Rapid clinical improvement, absence of eosinophilia, and confirmation of viral infection allow clinicians to avoid unnecessary life-long exclusion of aminopenicillins. 2
• Consider allergy testing (patch tests and delayed intradermal tests) to definitively establish or exclude delayed hypersensitivity before permanently labeling the patient as allergic. 10

Special Considerations

Influenza Vaccination and Rash

• Cutaneous reactions following influenza vaccination can include maculopapular (morbilliform) rashes, occurring in approximately 10% of reported cutaneous adverse events. 11
• These vaccine-related rashes are distinct from rashes occurring during active influenza infection with concurrent antibiotic use. 11

Severe Cutaneous Reactions Requiring Urgent Action

Immediately discontinue amoxicillin and seek specialist consultation if:

• Mucosal involvement develops (suggesting Stevens-Johnson syndrome or toxic epidermal necrolysis). 1
• Facial edema, fever, and systemic symptoms persist or worsen despite drug cessation. 1, 2
• Eosinophilia is present with organ involvement (suggesting DRESS syndrome). 1, 2